<DOC>
	<DOC>NCT01078753</DOC>
	<brief_summary>This is multi-center, randomized, placebo-controlled, parallel-group, double-blind, dose-escalating clinical trial designed to assess the efficacy and safety of desmopressin orally lyophilisate for the treatment of nocturnal enuresis "with decreased nighttime urinary osmolality."</brief_summary>
	<brief_title>Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis</brief_title>
	<detailed_description />
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Diagnosed nocturnal enuresis with reduced nighttime urinary osmolality Age 6 or above but under 16 regardless of gender Outpatient Had 10 or more wet nights during the 14day baseline period and at least 4 wet nights in each respective week Deemed healthy by the investigator Able to agree to and comply with fluidintake restriction during the clinical trial and matters specified in the clinical trial protocol Consent from the pediatric patient's legally acceptable representative Demonstrate an understanding about this clinical trial after receiving an explanation corresponding to the prospective subject's intelligibility Show no possibility of being a nursing mother or pregnant, or becoming pregnant If under drug or medical therapy other than Desmopressin for treating nocturnal enuresis: able to discontinue such treatment Suffer from enuresis with an underlying disease Participated in another clinical trial within six months preceding consent Used an intranasal Desmopressin in the past Presently undergoing a systemic antibiotic treatment, a treatment with an antidiuretic or a drug that affects urinary concentration, or a drug or medical therapy for overactive bladder Have an anomaly or a disease that may affect the oral absorption of drug products Hard to get cooperation from subject by school refusal, punishment or bullying Deemed by the investigator to be inappropriate to participate in this trial Unable to be placed on waterintake restriction starting from two hours before bedtime Evidence of hepatic, renal, cardiac, or pulmonary dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>